Developing vaccines to prevent Chlamydia infections
Bacteriophage virus-like particle vaccines for Chlamydia trachomatis urogenital infection
['FUNDING_R01'] · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · NIH-10991328
This study is looking at how to create vaccines that help your immune system fight off Chlamydia, a common sexually transmitted infection, to prevent serious health issues like infertility.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR (nih funded) |
| Locations | 1 site (ALBUQUERQUE, UNITED STATES) |
| Trial ID | NIH-10991328 on ClinicalTrials.gov |
What this research studies
This research focuses on creating vaccines that can stimulate the immune system to produce antibodies against Chlamydia trachomatis, a common sexually transmitted infection. The study aims to understand how the immune system responds to this infection and to identify specific proteins that can be targeted by vaccines. By engineering vaccine candidates that elicit strong antibody responses, the research seeks to provide a preventive measure against the serious health complications associated with Chlamydia, such as infertility and pelvic inflammatory disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are sexually active individuals, particularly women, who are at risk of Chlamydia infections.
Not a fit: Patients who are already infected with Chlamydia or those who have had previous infections may not benefit from this preventive vaccine.
Why it matters
Potential benefit: If successful, this research could lead to an effective vaccine that prevents Chlamydia infections and their associated long-term health issues.
How similar studies have performed: While there have been various approaches to developing vaccines for sexually transmitted infections, this specific method targeting Chlamydia is novel and has not been extensively tested.
Where this research is happening
ALBUQUERQUE, UNITED STATES
- UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR — ALBUQUERQUE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FRIETZE, KATHRYN M. — UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
- Study coordinator: FRIETZE, KATHRYN M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.